30-09-2026 17:09 via drugs.com

Effect of Semaglutide on MACE Risk Reduction Only Partly Explained by Known Risk Factors

WEDNESDAY, Sept. 30, 2026 -- The effects of semaglutide on major adverse cardiovascular events (MACE) is only partially due to known risk factors, according to a study published online Sept. 23 in the European Heart Journal.
Helen M. Colhoun, M.B...
Read more »

Pharmaceutical news



2016 to 2024 Saw Increase in Patients Using Medical Cannabis
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Midlife Employment Instability Linked to Later Cognitive Deficits
Elevated C-Reactive Protein Linked to Increased Risk for Incident Heart Failure, All-Cause Mortality
Two Charged In Scheme To Sell Counterfeit Ozempic — How You Can Spot Fake Meds
Low-Dose Radiation Could Help Slow Knee Arthritis
Injury Prevention And Recovery: Essential Guidelines Before Starting A New Workout Routine
Pediatricians' Group Updates Guidelines On UTIs In Babies, Kids
ER Admissions For E-Scooter Injuries Double In Two Years
Focused Brain Radiation Could Ease Severe, Tough-To-Treat Depression
She Left After Waiting Hours In The Emergency Room. The ER Billed Her Anyway.
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline
ACS: Mortality Elevated for Certain Common Emergency General Surgeries
Desktop versie